Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Anacor Pharmaceuticals Inc    ANAC   US0324201013

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/21/2014 07/22/2014 07/23/2014 07/24/2014 07/25/2014 Date
16.91(c) 16.45(c) 16.95(c) 17.34(c) 16.67(c) Last
2 225 130 547 558 917 051 403 078 247 011 Volume
+6.76% -2.72% +3.04% +2.30% -3.86% Change
More quotes
Company
Anacor Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company has discovered seven compounds that are currently in development including its lead... 
Surperformance© rating of Anacor Pharmaceuticals Inc
Trading Rating : Investor Rating :
More about the company
Chart ANACOR PHARMACEUTICALS INC
Duration : Period :
Anacor Pharmaceuticals Inc Technical Analysis Chart | ANAC | US0324201013 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 33,0 M
EBIT 2014 -92,1 M
Net income 2014 -94,9 M
Debt 2014 -
Yield 2014 -
Sales 2015 49,7 M
EBIT 2015 -93,0 M
Net income 2015 -94,4 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 22,0x
Capi. / Sales 2015 14,6x
Capitalization 727 M
More Financials
Latest news on ANACOR PHARMACEUTICALS INC
4d ago NOVARTIS : Sandoz obtains rights in us to commercialize kerydintm (tavaborole) t..
5d ago ANACOR PHARMACEUTICALS : Entry into a Material Definitive Agreement, Financial S..
5d ago ANACOR PHARMACEUTICALS : and Sandoz Enter Into an Agreement for the Commercializ..
07/16 ANACOR PHARMACEUTICALS : FDA Approves Anacor Pharmaceuticals' KERYDIN™ Tav..
07/10 ANACOR PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form 8..
07/09 ANACOR PHARMACEUTICALS : FDA approves first drug from Anacor Pharma
07/08 ANACOR PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form 8..
07/08 ANACOR PHARMACEUTICALS : FDA approves first drug from Anacor Pharma
07/08 ANACOR PHARMACEUTICALS : FDA Approves Anacor Pharmaceuticals' KERYDIN™ (Ta..
07/08 ANACOR PHARMACEUTICALS : FDA Approves Anacor Pharmaceuticals’ KERYDIN&trad..
06/11 ANACOR PHARMACEUTICALS : Appoints Keith R. Leonard, Jr. to Board of Directors
06/02 ANACOR PHARMACEUTICALS : Change in Directors or Principal Officers, Submission o..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
Anacor Pharmaceuticals Inc : Income Statement Evolution
More Financials
EPS Revisions
Anacor Pharmaceuticals Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF